Latest News

All the news from Anaphylaxis UK

Looking for Allergy Alerts?

Allergy Alerts

Latest News from Anaphylaxis UK

“We were told it was safe”: a family’s call for better allergy care for young adults   10th April 2026

Saavan and his family have been navigating life with serious food allergies since early childhood. While they have worked tirelessly to manage his condition, inconsistent access to specialist care and limited treatment options have created significant challenges along the way.
[…]

Read more
“I’ve been asked to leave restaurants and sign disclaimers” 8th April 2026

Allergies are often associated with childhood — but they can develop at any stage of life. For Hong, that moment came at 30, when she was diagnosed with serious allergies. Almost overnight, she had to completely rethink her diet, with
[…]

Read more
“I didn’t want to make a fuss – so I took risks I shouldn’t have” 7th April 2026

Luke first experienced a serious allergic reaction aged three and from that moment on, everyday life became about constant vigilance and staying safe in situations most of us take for granted. That vigilance was sometimes met with misunderstanding, exclusion, and
[…]

Read more

News Type:

2021 vaccine recommendations for children with food allergy or asthma 14th October 2021

The paediatric allergy group of the British Society for Allergy and Clinical Immunology have produced updated guidance for clinicians about vaccinations against COVID-19, Influenza and MMR for children with food allergy or asthma. You can read the new guidance here 

Read more
New BSACI 2021 guideline for the management of egg allergy 14th October 2021

Egg allergy most commonly presents in infancy and around 1 in 50 children has an egg allergy. An updated guideline for the management of egg allergy has been announced by the British Society for Allergy and Clinical Immunology (BSACI). The

Read more
Research on the economic burden caused by peanut allergy 12th October 2021

Kantar Health, an independent research agency, is collaborating with sponsoring company DBV Technologies, and with the assistance of Anaphylaxis Campaign, to conduct research on the economic burden caused by peanut allergy. In this context, Kantar Health  invite you to participate

Read more
Survey on the economic impact of peanut allergy 12th October 2021

The prevalence of peanut allergy is increasing in Western countries and is reported to be up to 3% among children.

Read more
Latest NHS figures show a decline in hospital admissions for allergy and anaphylaxis 5th October 2021

The 2020/2021 NHS hospital admissions figures for allergy and anaphylaxis have been published. Following 7 years of a steady increase in admissions, this year’s figures show a substantial decline in both allergy and anaphylaxis hospital admissions for adults and children.

Read more
Government process for applying for medical exemption from COVID-19 vaccination is now live 1st October 2021

The Department of Health and Social care have announced that the process for applying for official proof that you’re unable to be vaccinated is now live. One of the possible reasons for medical exemption listed is if you are ‘a

Read more
‘Natasha’s Law’ Comes into Force Today! 1st October 2021

Today is the long-awaited day that ‘Natasha’s Law’ for allergen labelling comes into force. If you are wondering what it means for you or your family, please take a look at this video. Our helpline is open 9am-5pm Mon-Fri to

Read more
York Health Economics Consortium (YHEC, University of York) Peanut Allergy Research 24th September 2021

York Health Economics Consortium (YHEC, University of York) is running a survey to study how peanut allergy impacts on children’s quality of life. The results of the survey will not only help them better understand how peanut allergy affects a

Read more
JCVI issues updated COVID-19 Booster advice – AstraZeneca vaccine can be considered for those who had it previously due to allergies 16th September 2021

The Joint Committee on Vaccination and Immunisation (JCVI) has updated its advice on the COVID-19 vaccine booster programme. The full announcement can be read here :- JCVI Issues updated advice on COVID-19 booster vaccination Of particular note for people with allergies

Read more